Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program
November 08, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait
November 03, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies (NASDAQ: HSDT) will showcase its innovative new Portable Neuromodulation Stimulator (PoNS®) at the 99th annual American...
Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022
November 01, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait
October 13, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Oct. 13, 2022 (GLOBE NEWSWIRE) -- National Physical Therapy Month (NPTM) comes every October, but this one is particularly meaningful to Helius Medical Technologies (NASDAQ: HSDT):...
Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference
September 29, 2022 17:20 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
September 14, 2022 17:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September
September 06, 2022 06:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results
August 15, 2022 16:05 ET
|
Helius Medical Technologies, Inc.
-- Net proceeds from August 2022 financing and cash on hand expected to fund operations through 2023 ---- Company to host call at 4:30pm today -- NEWTOWN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) --...
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022
August 10, 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering
August 05, 2022 08:38 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...